聚电解质纳米颗粒来源于杜连种子的,经基托修饰,用于选择性向癌细胞
Jindrayani Nyoo Putro1, Fasih Bintang Ilhami2, Chih-Chia Cheng3
1Chemical Engineering Master Program, Faculty of Engineering, Widya Mandala Surabaya Catholic University, Kalijudan 37, Surabaya 60114, Indonesia; Collaborative Research Center for Sustainable and Zero Waste Industries, Jl. Kalijudan 37, Surabaya 60114, East Java, Indonesia.
International journal of biological macromolecules
|May 25, 2025
概括
研究人员从榴莲种子和奇托中开发了新的纳米粒子. 这些生物相容的纳米粒子显示选择性光用于追踪癌细胞,提供了一个有前途的绿色合成方法.
科学领域:
- 材料科学 材料科学 材料科学
- 生物技术是生物技术.
- 纳米技术 纳米技术
背景情况:
- 自然的多糖为纳米粒子开发提供生物相容的平台.
- 素修饰可以增强天然聚合物的特性.
- 榴莲种子是一种未充分利用的生物材料来源.
研究的目的:
- 为了合成和表征复杂的纳米颗粒使用榴莲种子改性奇多.
- 评估开发的纳米粒子的pH响应性行为,稳定性和生物相容性.
- 为了研究这些纳米粒子通过光追踪癌细胞的潜力.
主要方法:
- 复杂的纳米粒子形成使用榴莲种子和奇托.
- 通过H NMR,ZETA潜力,SEM,FTIR,光谱仪进行表征.
- 评估pH反应性胀,动力稳定性,溶血活性和细胞毒性 (NIH / 3T3和HeLa细胞).
主要成果:
- 通过H NMR证实了相互透的聚合物网络纳米粒子的成功合成.
- 证明了pH反应性胀,在酸性pH (2.1) 时的胀比中性 (5.5,7.4) 时的胀更高.
- 基托桑修饰增强了动力稳定性;纳米颗粒表现出良好的血液兼容性 (4%的溶血活性) 和对HeLa癌细胞的选择性细胞毒性.
- 观察到强烈的细胞内蓝色光,表明癌细胞跟踪的潜力.
结论:
- 榴莲种子改性奇托桑纳米颗粒的绿色合成是可行的.
- 这些纳米粒子表现出理想的特性,包括pH响应性,稳定性,生物相容性和选择性光.
- 这些纳米粒子在向癌细胞成像和诊断方面表现有前途.
更多相关视频
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
141
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
141
Site-Targeted Drug Delivery Systems: Polymeric Carriers
127
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
127


